Astellas Pharma Inc. (TYO:4503)
Japan · Delayed Price · Currency is JPY 1,703.50
+90.00 (5.58%)
Nov 4, 2025, 3:30 PM JST
Astellas Pharma Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 2,006,816 | 1,912,323 | 1,603,672 | 1,518,619 | 1,296,163 | 1,249,528 | Upgrade | |
Revenue Growth (YoY) | 13.24% | 19.25% | 5.60% | 17.16% | 3.73% | -3.94% | Upgrade |
Cost of Revenue | 375,740 | 349,206 | 292,485 | 288,353 | 253,009 | 246,063 | Upgrade |
Gross Profit | 1,631,076 | 1,563,117 | 1,311,187 | 1,230,266 | 1,043,154 | 1,003,465 | Upgrade |
Selling, General & Admin | 840,455 | 843,032 | 740,110 | 630,272 | 548,840 | 504,316 | Upgrade |
Research & Development | 298,610 | 327,651 | 294,187 | 276,128 | 246,010 | 224,489 | Upgrade |
Other Operating Expenses | 20,845 | -7,868 | 53,464 | 53,778 | 1,876 | -35 | Upgrade |
Operating Expenses | 1,292,930 | 1,299,577 | 1,186,581 | 998,614 | 825,009 | 752,533 | Upgrade |
Operating Income | 338,146 | 263,540 | 124,606 | 231,652 | 218,145 | 250,932 | Upgrade |
Interest Expense | -16,725 | -13,952 | -7,423 | -3,217 | -2,315 | -2,118 | Upgrade |
Interest & Investment Income | 6,819 | 6,885 | 8,851 | 5,253 | 862 | 760 | Upgrade |
Earnings From Equity Investments | -3,289 | -259 | -3,165 | 1,260 | 489 | 478 | Upgrade |
Currency Exchange Gain (Loss) | -18,600 | -18,578 | -807 | -10,124 | 8,172 | -2,332 | Upgrade |
Other Non Operating Income (Expenses) | -1 | -218 | -1,723 | 2,303 | -2,431 | 72 | Upgrade |
EBT Excluding Unusual Items | 306,350 | 237,418 | 120,339 | 227,127 | 222,922 | 247,792 | Upgrade |
Merger & Restructuring Charges | -15,500 | -15,523 | -25,407 | -4,510 | -19,556 | -9,293 | Upgrade |
Gain (Loss) on Sale of Investments | - | -2,516 | -253 | -5,007 | 5,084 | 10,558 | Upgrade |
Gain (Loss) on Sale of Assets | 4,151 | 1,049 | 9,735 | 212 | 24,234 | 24 | Upgrade |
Asset Writedown | -174,900 | -187,618 | -78,931 | -83,964 | -74,850 | -101,746 | Upgrade |
Legal Settlements | - | -1,573 | -514 | -1,497 | -948 | -2,012 | Upgrade |
Pretax Income | 136,801 | 31,237 | 24,969 | 132,361 | 156,886 | 145,323 | Upgrade |
Income Tax Expense | 11,930 | -19,510 | 7,924 | 33,647 | 32,800 | 24,734 | Upgrade |
Net Income | 124,871 | 50,747 | 17,045 | 98,714 | 124,086 | 120,589 | Upgrade |
Net Income to Common | 124,871 | 50,747 | 17,045 | 98,714 | 124,086 | 120,589 | Upgrade |
Net Income Growth | 128.09% | 197.72% | -82.73% | -20.45% | 2.90% | -38.29% | Upgrade |
Shares Outstanding (Basic) | 1,790 | 1,790 | 1,793 | 1,820 | 1,850 | 1,857 | Upgrade |
Shares Outstanding (Diluted) | 1,797 | 1,797 | 1,800 | 1,825 | 1,851 | 1,858 | Upgrade |
Shares Change (YoY) | -0.07% | -0.14% | -1.39% | -1.38% | -0.41% | -1.03% | Upgrade |
EPS (Basic) | 69.74 | 28.35 | 9.50 | 54.24 | 67.08 | 64.93 | Upgrade |
EPS (Diluted) | 69.49 | 28.24 | 9.47 | 54.09 | 67.05 | 64.90 | Upgrade |
EPS Growth | 128.29% | 198.21% | -82.49% | -19.33% | 3.31% | -37.64% | Upgrade |
Free Cash Flow | 366,051 | 157,509 | 134,419 | 291,326 | 226,705 | 275,459 | Upgrade |
Free Cash Flow Per Share | 203.69 | 87.64 | 74.69 | 159.63 | 122.50 | 148.24 | Upgrade |
Dividend Per Share | 37.000 | 74.000 | 70.000 | 60.000 | 50.000 | 42.000 | Upgrade |
Dividend Growth | -65.42% | 5.71% | 16.67% | 20.00% | 19.05% | 5.00% | Upgrade |
Gross Margin | 81.28% | 81.74% | 81.76% | 81.01% | 80.48% | 80.31% | Upgrade |
Operating Margin | 16.85% | 13.78% | 7.77% | 15.25% | 16.83% | 20.08% | Upgrade |
Profit Margin | 6.22% | 2.65% | 1.06% | 6.50% | 9.57% | 9.65% | Upgrade |
Free Cash Flow Margin | 18.24% | 8.24% | 8.38% | 19.18% | 17.49% | 22.05% | Upgrade |
EBITDA | 532,091 | 462,672 | 282,446 | 337,390 | 297,829 | 323,584 | Upgrade |
EBITDA Margin | 26.51% | 24.19% | 17.61% | 22.22% | 22.98% | 25.90% | Upgrade |
D&A For EBITDA | 193,945 | 199,132 | 157,840 | 105,738 | 79,684 | 72,652 | Upgrade |
EBIT | 338,146 | 263,540 | 124,606 | 231,652 | 218,145 | 250,932 | Upgrade |
EBIT Margin | 16.85% | 13.78% | 7.77% | 15.25% | 16.83% | 20.08% | Upgrade |
Effective Tax Rate | 8.72% | - | 31.74% | 25.42% | 20.91% | 17.02% | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.